Home
Conditions
Bladder Cancer

Clinical trial condition

Bladder Cancer

Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.

771 public trials 174 recruiting studies

Refine in advanced search Browse all conditions

Bladder Cancer trial results

Completed

Hyperthermic Intra-Vesical Chemotherapy

NCT06768346

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Royal United Hospitals Bath NHS Foundation Trust Bath, United Kingdom

Western General Hospital, Edinburgh Edinburgh, United Kingdom

Royal Surrey County Hospital NHS Foudation Trust Guildford, United Kingdom

The Clatterbridge Cancer Centre Liverpool, United Kingdom

View all 14 locations

View Trial Details

Completed

CLEAR Care Companion Application

NCT05578898

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations: University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Completed

FITBIT Study on Mobility and Readmissions After Radical Cystectomy

NCT04314778

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Abramson Cancer Center Philadelphia, Pennsylvania, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

The Registry of Oncology Outcomes Associated With Testing and Treatment

NCT04028479

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +249 more
Locations: Teton Cancer Institute Idaho Falls, Idaho, United States

Oncology and Hematology of South Texas Laredo, Texas, United States

View Trial Details

Completed

Lymph Node Dissection Before or After Cystectomy

NCT05939856

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Department of Urology, University Hospital, Jagiellonian University Krakow, Poland

View Trial Details

Completed

Immunological Response of Bladder Cancer Patients Under BCG

NCT04806178

Conditions: Bacillus Calmette-Guerin, Bladder Cancer, Female Urogenital Diseases, +10 more
Locations: Pontifical Catholic University of Campinas Hospital Campinas, São Paulo, Brazil

Hospital das Clínicas Unicamp Campinas, São Paulo, Brazil

View Trial Details

Completed

S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

NCT01224665

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Los Angeles County-USC Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

Stanford Cancer Institute Palo Alto, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View all 35 locations

View Trial Details

Completed

Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma

NCT03534804

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Winship Cancer Institute, Emory University Atlanta, Georgia, United States

Huntsman Cancer Institute Salt Lake City, Utah, United States

View Trial Details

Completed

The Impact of Intrathecal Morphine Versus Continuous Epidural Analgesia on Return of Bowel Function in Patients Undergoing Laparoscopic Ileal Conduit

NCT06688643

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +21 more
Locations: Inner Mongolia Baogang Hospital Baotou, Inner Mongolia, China

View Trial Details

Completed

Mood Disorders Bladder Cancer

NCT04036877

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: University of Kansas Health System Kansas City, Kansas, United States

View Trial Details

Bladder Cancer

Bladder Cancer trial results

Related conditions